FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SP1-IGFBP6

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SP1-IGFBP6
FusionPDB ID: 85384
FusionGDB2.0 ID: 85384
HgeneTgene
Gene symbol

SP1

IGFBP6

Gene ID

199699

3489

Gene nameDAN domain BMP antagonist family member 5insulin like growth factor binding protein 6
SynonymsCER2|CERL2|CKTSF1B3|COCO|CRL2|DANTE|GREM3|SP1IBP6
Cytomap

19p13.13

12q13.13

Type of geneprotein-codingprotein-coding
DescriptionDAN domain family member 5DAN domain family member 5, BMP antagonistDAN domain family, member 5cerberus 2cerberus-like 2cerberus-like protein 2cerl-2cysteine knot superfamily 1, BMP antagonist 3gremlin-3insulin-like growth factor-binding protein 6IBP-6IGF binding protein 6IGFBP-6
Modification date2020031320200313
UniProtAcc

SP110

Main function of 5'-partner protein: 689

P24592

Main function of 5'-partner protein: FUNCTION: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Activates the MAPK signaling pathway and induces cell migration (PubMed:24003225). {ECO:0000269|PubMed:24003225}.
Ensembl transtripts involved in fusion geneENST idsENST00000327443, ENST00000426431, 
ENST00000549628, ENST00000301464, 
ENST00000548547, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score11 X 8 X 6=5286 X 5 X 4=120
# samples 116
** MAII scorelog2(11/528*10)=-2.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/120*10)=-1
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SP1 [Title/Abstract] AND IGFBP6 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SP1 [Title/Abstract] AND IGFBP6 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SP1(53777406)-IGFBP6(53494496), # samples:2
Anticipated loss of major functional domain due to fusion event.SP1-IGFBP6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SP1-IGFBP6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SP1-IGFBP6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SP1-IGFBP6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:53777406/chr12:53494496)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SP1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across IGFBP6 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000327443SP1chr1253777406+ENST00000548547IGFBP6chr1253494496+23341773982155685
ENST00000327443SP1chr1253777406+ENST00000301464IGFBP6chr1253494496+23351773982161687
ENST00000426431SP1chr1253777406+ENST00000548547IGFBP6chr1253494496+22751714272096689
ENST00000426431SP1chr1253777406+ENST00000301464IGFBP6chr1253494496+22761714272102691

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000327443ENST00000548547SP1chr1253777406+IGFBP6chr1253494496+0.0275476430.9724523
ENST00000327443ENST00000301464SP1chr1253777406+IGFBP6chr1253494496+0.0277577140.97224236
ENST00000426431ENST00000548547SP1chr1253777406+IGFBP6chr1253494496+0.0320979250.96790206
ENST00000426431ENST00000301464SP1chr1253777406+IGFBP6chr1253494496+0.0305425490.9694575

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SP1-IGFBP6

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SP1chr1253777406IGFBP6chr12534944961714561HPIQGLPLAIANAPVAEENPKESKPQ
SP1chr1253777406IGFBP6chr12534944961714562PIQGLPLAIANAPEENPKESKPQAGT
SP1chr1253777406IGFBP6chr12534944961773557HPIQGLPLAIANAPVAEENPKESKPQ
SP1chr1253777406IGFBP6chr12534944961773558PIQGLPLAIANAPEENPKESKPQAGT

Top

Potential FusionNeoAntigen Information of SP1-IGFBP6 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SP1-IGFBP6_53777406_53494496.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SP1-IGFBP6chr1253777406chr12534944961773HLA-B56:01LPLAIANAPV0.99370.7238515
SP1-IGFBP6chr1253777406chr12534944961773HLA-B56:01LPLAIANAPVA0.99730.734516
SP1-IGFBP6chr1253777406chr12534944961773HLA-B54:01LAIANAPVA0.99690.7495716
SP1-IGFBP6chr1253777406chr12534944961773HLA-B54:01LPLAIANAPV0.99840.9275515
SP1-IGFBP6chr1253777406chr12534944961773HLA-B54:01LPLAIANAPVA0.99960.9172516
SP1-IGFBP6chr1253777406chr12534944961773HLA-B78:02LAIANAPVA0.91260.9776716
SP1-IGFBP6chr1253777406chr12534944961773HLA-B55:02LPLAIANAPVA0.99770.8199516

Top

Potential FusionNeoAntigen Information of SP1-IGFBP6 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SP1-IGFBP6_53777406_53494496.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0102GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0403PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0403LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0403GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0403GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0405PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0405LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0409PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0409LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411LAIANAPVAEENPKE722
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0411QGLPLAIANAPEENP217
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0413GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0413PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0415GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0417PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0417LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0417GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0424PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0427PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0427LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0427GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0429PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0429LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0430PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0430LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0436GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0439PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0439LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0439GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0439GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0440GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0441PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0441LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0441GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0441GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0444GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0445PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0445LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0446PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0446LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0446GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0446GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0448PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0448LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0449PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0449GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0449LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0449GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0450PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0450LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0450GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0450GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0451PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0451LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0451GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0452PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0452LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0452GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0452GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0455GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0455PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0457PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0457LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0458GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0459PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0459LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0459GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0460PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0460LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0460GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0460GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0462PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0462LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0465PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0465GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0465LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467LAIANAPVAEENPKE722
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0467QGLPLAIANAPEENP217
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0468GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0469PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0470GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0471PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0471LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0471GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0471GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0477PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0477LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0478GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0478PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0478LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0478QGLPLAIANAPVAEE318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0479GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0479PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0480PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0480LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0483PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0483LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0484PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0484LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0485PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0485LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0485GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0485GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0487PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0487LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0488PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0488LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0488GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0489PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0489LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491LAIANAPVAEENPKE722
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491GLPLAIANAPEENPK318
SP1-IGFBP6chr1253777406chr12534944961773DRB1-0491QGLPLAIANAPEENP217
SP1-IGFBP6chr1253777406chr12534944961773DRB1-1002GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-1410PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB1-1410LPLAIANAPVAEENP520
SP1-IGFBP6chr1253777406chr12534944961773DRB1-1410GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB1-1457PLAIANAPVAEENPK621
SP1-IGFBP6chr1253777406chr12534944961773DRB3-0201GLPLAIANAPVAEEN419
SP1-IGFBP6chr1253777406chr12534944961773DRB3-0224GLPLAIANAPVAEEN419

Top

Fusion breakpoint peptide structures of SP1-IGFBP6

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6754PLAIANAPVAEENPSP1IGFBP6chr1253777406chr12534944961773

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SP1-IGFBP6

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6754PLAIANAPVAEENP-6.95813-7.07543
HLA-B14:023BVN6754PLAIANAPVAEENP-5.24044-6.27964
HLA-B52:013W396754PLAIANAPVAEENP-6.59273-6.71003
HLA-B52:013W396754PLAIANAPVAEENP-5.15338-6.19258
HLA-A24:025HGA6754PLAIANAPVAEENP-7.00931-7.12661
HLA-A24:025HGA6754PLAIANAPVAEENP-5.94433-6.98353
HLA-B44:053DX86754PLAIANAPVAEENP-7.88397-8.00127
HLA-B44:053DX86754PLAIANAPVAEENP-3.38477-4.42397

Top

Vaccine Design for the FusionNeoAntigens of SP1-IGFBP6

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SP1-IGFBP6chr1253777406chr1253494496515LPLAIANAPVCGTTGGCTATAGCAAATGCCCCAGTTGCAG
SP1-IGFBP6chr1253777406chr1253494496516LPLAIANAPVACGTTGGCTATAGCAAATGCCCCAGTTGCAGAGG
SP1-IGFBP6chr1253777406chr1253494496716LAIANAPVACTATAGCAAATGCCCCAGTTGCAGAGG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SP1-IGFBP6chr1253777406chr1253494496217QGLPLAIANAPEENPAAGGCCTGCCGTTGGCTATAGCAAATGCCCCAGAGGAGAATCCTA
SP1-IGFBP6chr1253777406chr1253494496318GLPLAIANAPEENPKGCCTGCCGTTGGCTATAGCAAATGCCCCAGAGGAGAATCCTAAGG
SP1-IGFBP6chr1253777406chr1253494496318QGLPLAIANAPVAEEGCCTGCCGTTGGCTATAGCAAATGCCCCAGTTGCAGAGGAGAATC
SP1-IGFBP6chr1253777406chr1253494496419GLPLAIANAPVAEENTGCCGTTGGCTATAGCAAATGCCCCAGTTGCAGAGGAGAATCCTA
SP1-IGFBP6chr1253777406chr1253494496520LPLAIANAPVAEENPCGTTGGCTATAGCAAATGCCCCAGTTGCAGAGGAGAATCCTAAGG
SP1-IGFBP6chr1253777406chr1253494496621PLAIANAPVAEENPKTGGCTATAGCAAATGCCCCAGTTGCAGAGGAGAATCCTAAGGAGA
SP1-IGFBP6chr1253777406chr1253494496722LAIANAPVAEENPKECTATAGCAAATGCCCCAGTTGCAGAGGAGAATCCTAAGGAGAGTA

Top

Information of the samples that have these potential fusion neoantigens of SP1-IGFBP6

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCSSP1-IGFBP6chr1253777406ENST00000327443chr1253494496ENST00000301464TCGA-N7-A59B-01A

Top

Potential target of CAR-T therapy development for SP1-IGFBP6

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SP1-IGFBP6

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SP1-IGFBP6

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource